Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this meta-analysis was to determine the efficacy and safety of glyburide as a treatment for gestational diabetes mellitus (GDM) compared to insulin. METHODS: A meta-analysis was conducted to compare the management of gestational diabetes with glyburide and insulin. Studies fulfilling all of the following inclusion criteria were included in this meta-analysis: subjects were women with gestational diabetes requiring drug treatment; the comparison treatment included glyburide vs insulin; one or more outcomes (maternal or neonatal) should be provided in the individual study; the study design should be a randomized control trial. Exclusion criteria: non-RCT studies; non-human data. PubMed, Embase and CENTRAL databases were searched from inception until 10 October 2016. RESULTS: Ten randomized control trials involving 1194 participants met the inclusion criteria and were included. 13 primary outcomes (6 maternal, 7 neonatal) and 26 secondary outcomes (9 maternal, 17 neonatal) were detected and analyzed in this study. Glyburide significantly increased the risk of any neonatal hypoglycemia [risk ratio (RR), 1.89; 95% confidence interval (95%CI), 1.26 to 2.82; p = 0.002]. Sensitivity analysis confirmed robustness of this result [RR, 2.29; 95%CI, 1.49 to 3.54; p = 0.0002]. No differences were observed between the two groups with respect to birth weights [mean difference (MD), 79; 95%CI, -64 to 221.99; p = 0.28] and the risk of macrosomia [RR, 1.69; 95%CI, 0.57 to 5.08; p = 0.35]. CONCLUSION: For women with gestational diabetes, no differences in maternal short term outcomes were observed in those treated with glyburide or insulin. However, the incidence of neonatal hypoglycemia was higher in the glyburide group compared to the insulin group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent data have raised concern about increased risk of adverse outcomes with use of glyburide compared with insulin, including increased risk of macrosomia64 and neonatal hypoglycemia.64,65”
From Gestational Diabetes Mellitus (2019) · cites this paper as [65]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Gestational diabetes: the need for a common ground
Reece, E. A., Leguizamón, G., & Wiznitzer, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60515-8 · Cited by 589
Balsells, M., Garcia-Patterson, A., Sola, I., Roque, M., Gich, I., & Corcoy, R. (2015) · BMJ · doi:10.1136/bmj.h102 · Cited by 498
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-er09 · Cited by 379
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
Lowe, L. P., Metzger, B. E., Dyer, A. R., Lowe, J., McCance, D. R., Lappin, T. R. J., Trimble, E. R., Coustan, D. R., Hadden, D. R., Hod, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1687 · Cited by 367
Metformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Treatments for gestational diabetes
Alwan, N., Tuffnell, D. J., & West, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003395.pub2 · Cited by 214
Camelo Castillo, W., Boggess, K., Stürmer, T., Brookhart, M. A., Benjamin, D. K., & Jonsson Funk, M. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.74 · Cited by 177
Jacobson, G. F., Ramos, G. A., Ching, J. Y., Kirby, R. S., Ferrara, A., & Field, D. R. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.018 · Cited by 177
Perinatal outcomes and the use of oral hypoglycemic agents
Bertini, A. M., Silva, J. C., Taborda, W., Becker, F., Bebber, F. R. L., Viesi, J. M. Z., Aquim, G., & Ribeiro, T. E. (2005) · Journal of Perinatal Medicine · doi:10.1515/jpm.2005.092 · Cited by 161
Nicholson, W., Bolen, S., Witkop, C. T., Neale, D., Wilson, L., & Bass, E. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318190a459 · Cited by 161
Dhulkotia, J. S., Ola, B., Fraser, R., & Farrell, T. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.06.044 · Cited by 145
Balani, J., Hyer, S. L., Rodin, D. A., & Shehata, H. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02780.x · Cited by 145
Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcome
Langer, O., Yogev, Y., Xenakis, E. M.-J., & Rosenn, B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.07.011 · Cited by 140
Jiang, Y.-F., Chen, X.-Y., Ding, T., Wang, X.-F., Zhu, Z.-N., & Su, S.-W. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4403 · Cited by 124
Nachum, Z., Zafran, N., Salim, R., Hissin, N., Hasanein, J., Gam Ze Letova, Y., Suleiman, A., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dc16-2307 · Cited by 118
Metformin compared with glyburide for the management of gestational diabetes
Silva, J. C., Pacheco, C., Bizato, J., de Souza, B. V., Ribeiro, T. E., & Bertini, A. M. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.04.028 · Cited by 115
Poolsup, N., Suksomboon, N., & Amin, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109985 · Cited by 107
Anjalakshi, C., Balaji, V., Balaji, M. S., & Seshiah, V. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.031 · Cited by 104
Lain, K. Y., Garabedian, M. J., Daftary, A., & Jeyabalan, A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.02.038 · Cited by 100
Updated guidelines on screening for gestational diabetes
Gupta, Y., Kalra, B., Baruah, M. P., Singla, R., & Kalra, S. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s82046 · Cited by 97
The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis
Zeng, Y.-C., Li, M.-J., Chen, Y., Jiang, L., Wang, S.-M., Mo, X.-L., & Li, B.-Y. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.03.001 · Cited by 76
Self-citationComparison of Glyburide versus Insulin in Management of Gestational Diabetes Mellitus
Ogunyemi, D. A., Jesse, M., & Davidson, M. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.427 · Cited by 74
Agarwal, M., Dhatt, G. S., & Othman, Y. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.03.006 · Cited by 73
Cheng, Y. W., Chung, J. H., Block-Kurbisch, I., Inturrisi, M., & Caughey, A. B. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.580402 · Cited by 72
Glyburide as treatment option for gestational diabetes mellitus
Tempe, A., & Mayanglambam, R. D. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12042 · Cited by 71
Olagbuji, B. N., Atiba, A. S., Olofinbiyi, B. A., Akintayo, A. A., Awoleke, J. O., Ade-Ojo, I. P., & Fasubaa, O. B. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.02.030 · Cited by 69
Su, D. F., & Wang, X. Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.056 · Cited by 57
De Seymour, J., Chia, A., Colega, M., Jones, B., McKenzie, E., Shirong, C., Godfrey, K., Kwek, K., Saw, S.-M., Conlon, C., et al. (2016) · Nutrients · doi:10.3390/nu8090574 · Cited by 57
Mukhopadhyay, P., Bag, T. S., Kyal, A., Saha, D. P., & Khalid, N. (2012) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1167 · Cited by 56
Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study
Koo, B. K., Lee, J. H., Kim, J., Jang, E. J., & Lee, C.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153107 · Cited by 55
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Malek, R., & Davis, S. N. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1187131 · Cited by 54
Considerations in the Management of Gestational Diabetes Mellitus: “You Are What Your Mother Ate!”
Moses, R. G., & Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dci15-0030 · Cited by 53
Huhn, E. A., Massaro, N., Streckeisen, S., Manegold-Brauer, G., Schoetzau, A., Schulzke, S. M., Winzeler, B., Hoesli, I., & Lapaire, O. (2017) · Journal of Perinatal Medicine · doi:10.1515/jpm-2016-0099 · Cited by 47
Ramos, G. A., Jacobson, G. F., Kirby, R. S., Ching, J. Y., & Field, D. R. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211683 · Cited by 44
Glibenclamida no tratamento do diabete melito gestacional em estudo comparado à insulina
Silva, J. C., Bertini, A. M., Taborda, W., Becker, F., Bebber, F. R. L., Aquim, G. M. D. C., & Viesi, J. M. Z. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400007 · Cited by 42
Saberi, F., Behrashi, M., Samimi, M., Ghasemi, T., & Atoof, F. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.184502 · Cited by 37
Mirzamoradi, M., Heidar, Z., Faalpoor, Z., Naeiji, Z., & Jamali, R. (2015) · PubMed · Cited by 35
Is Glyburide Safe in Pregnancy?
Kimber-Trojnar, Ż., Marciniak, B., Patro-Małysza, J., Skórzyńska-Dziduszko, K., Poniedziałek‐Czajkowska, E., Mierzyński, R., Gałczyński, K., Trojnar, M. P., Leszczyńska‐Gorzelak, B., & Oleszczuk, J. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140330200254 · Cited by 20
Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy
Pedersen, M. L., Olesen, J., Jørgensen, M. E., & Damm, P. (2016) · International Journal of Circumpolar Health · doi:10.3402/ijch.v75.32167 · Cited by 16
Herath, H. M. M., Weerarathna, T. P., & Weerasinghe, N. P. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.188084 · Cited by 12
Cited by
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 470
Szmuilowicz, E. D., Josefson, J. L., & Metzger, B. E. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.001 · Cited by 364
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Metadata
- Authors
- Song, R., Chen, L., Chen, Y., Si, X., Liu, Y., Liu, Y., Irwin, D. M., & Feng, W.
- Affiliations
- Peking University People's Hospital (CN)
- University of Toronto (CA)
- Corresponding author
- Irwin, David M.
- Feng, Wanyu
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-08-03
- Volume
- 12
- Issue
- 8
- Pages
- e0182488
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5542468
- OpenAlex
- W2744038916
- Cited by
- 73
- References
- 43
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 29 · 2020: 11 · 2019: 5 · 2018: 10 · 2017: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- gestational diabetes mellitus, glibenclamide, insulin therapy, neonatal hypoglycemia, macrosomia, birth weight, maternal outcomes, neonatal outcomes, antidiabetic drug comparison
- MeSH terms
- Adult, Birth Weight, Female, Glyburide, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Infant, Newborn, Diseases, Insulin, Pregnancy, Research Design, Incidence, Randomized Controlled Trials as Topic, Diabetes, Gestational, Treatment Outcome, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.